GW856553X

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW856553X, covering 2017-07-18 to 2017-07-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GW856553X For the Treatment of Depression [Phase 2]